Dietary Carcinogens and DNA Adducts in Prostate Cancer

Overview

Journal Adv Exp Med Biol

Specialties Biology
General Medicine

Date 2020 Jan 5

PMID 31900903

Citations 8

Authors

Medjda Bellamri

Robert J Turesky

Affiliations

Soon will be listed here.

Abstract

Prostate cancer (PC) is the most commonly diagnosed non-cutaneous cancer and the second leading cause of cancer-related to death in men. The major risk factors for PC are age, family history, and African American ethnicity. Epidemiological studies have reported large geographical variations in PC incidence and mortality, and thus lifestyle and dietary factors influence PC risk. High fat diet, dairy products, alcohol and red meats, are considered as risk factors for PC. This book chapter provides a comprehensive, literature-based review on dietary factors and their molecular mechanisms of prostate carcinogenesis. A large portion of our knowledge is based on epidemiological studies where dietary factors such as cancer promoting agents, including high-fat, dairy products, alcohol, and cancer-initiating genotoxicants formed in cooked meats have been evaluated for PC risk. However, the precise mechanisms in the etiology of PC development remain uncertain. Additional animal and human cell-based studies are required to further our understandings of risk factors involved in PC etiology. Specific biomarkers of chemical exposures and DNA damage in the prostate can provide evidence of cancer-causing agents in the prostate. Collectively, these studies can improve public health research, nutritional education and chemoprevention strategies.

Citing Articles

Prostate cancer incidence and mortality linked to metalworking fluid exposure: a systematic review and meta-analysis.

Moradpour Z, Barik A, Jorjani G, Taherian M, Tousizadeh S, Halimi A Front Oncol. 2025; 14:1491159.

PMID: 39950100 PMC: 11821483. DOI: 10.3389/fonc.2024.1491159.

FCGR3A: A new biomarker with potential prognostic value for prostate cancer.

Zha Z, Hong Y, Tang Z, Du Q, Wang Y, Yang S Front Oncol. 2022; 12:1014888.

PMID: 36505767 PMC: 9730230. DOI: 10.3389/fonc.2022.1014888.

The most effective but largely ignored target for prostate cancer early detection and intervention.

Man Y, Mannion C, Jewett A, Hsiao Y, Liu A, Semczuk A J Cancer. 2022; 13(13):3463-3475.

PMID: 36313040 PMC: 9608211. DOI: 10.7150/jca.72973.

The Utilization of Physiologically Active Molecular Components of Grape Seeds and Grape Marc.

Hegedus I, Andreidesz K, Szentpeteri J, Kaleta Z, Szabo L, Szigeti K Int J Mol Sci. 2022; 23(19).

PMID: 36232467 PMC: 9570270. DOI: 10.3390/ijms231911165.

Association Between Red and Processed Meat Consumption and Risk of Prostate Cancer: A Systematic Review and Meta-Analysis.

Nouri-Majd S, Salari-Moghaddam A, Aminianfar A, Larijani B, Esmaillzadeh A Front Nutr. 2022; 9:801722.

PMID: 35198587 PMC: 8859108. DOI: 10.3389/fnut.2022.801722.

References

Price R, Cavazos D, De Angel R, Hursting S, deGraffenried L . Obesity-related systemic factors promote an invasive phenotype in prostate cancer cells. Prostate Cancer Prostatic Dis. 2012; 15(2):135-43. DOI: 10.1038/pcan.2011.54. View

Wolk A, Mantzoros C, Andersson S, Bergstrom R, Signorello L, Lagiou P . Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study. J Natl Cancer Inst. 1998; 90(12):911-5. DOI: 10.1093/jnci/90.12.911. View

Fiorelli G, De Bellis A, Longo A, Giannini S, Natali A, Costantini A . Insulin-like growth factor-I receptors in human hyperplastic prostate tissue: characterization, tissue localization, and their modulation by chronic treatment with a gonadotropin-releasing hormone analog. J Clin Endocrinol Metab. 1991; 72(4):740-6. DOI: 10.1210/jcem-72-4-740. View

Nakai Y, Nelson W, De Marzo A . The dietary charred meat carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine acts as both a tumor initiator and promoter in the rat ventral prostate. Cancer Res. 2007; 67(3):1378-84. DOI: 10.1158/0008-5472.CAN-06-1336. View

Lim W, Jeong M, Bazer F, Song G . Coumestrol Inhibits Proliferation and Migration of Prostate Cancer Cells by Regulating AKT, ERK1/2, and JNK MAPK Cell Signaling Cascades. J Cell Physiol. 2016; 232(4):862-871. DOI: 10.1002/jcp.25494. View

Keating G, Bogen K . Estimates of heterocyclic amine intake in the US population. J Chromatogr B Analyt Technol Biomed Life Sci. 2004; 802(1):127-33. DOI: 10.1016/j.jchromb.2003.10.047. View

Takahashi S, Tamano S, Hirose M, Kimoto N, Ikeda Y, Sakakibara M . Immunohistochemical demonstration of carcinogen-DNA adducts in tissues of rats given 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP): detection in paraffin-embedded sections and tissue distribution. Cancer Res. 1998; 58(19):4307-13. View

Majumder P, Sellers W . Akt-regulated pathways in prostate cancer. Oncogene. 2005; 24(50):7465-74. DOI: 10.1038/sj.onc.1209096. View

Zhao J, Stockwell T, Roemer A, Chikritzhs T . Is alcohol consumption a risk factor for prostate cancer? A systematic review and meta-analysis. BMC Cancer. 2016; 16(1):845. PMC: 5109713. DOI: 10.1186/s12885-016-2891-z. View

10.

Magagnotti C, Pastorelli R, Pozzi S, Andreoni B, Fanelli R, Airoldi L . Genetic polymorphisms and modulation of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-DNA adducts in human lymphocytes. Int J Cancer. 2003; 107(6):878-84. DOI: 10.1002/ijc.11492. View

11.

Stattin P, Bylund A, Rinaldi S, Biessy C, Dechaud H, Stenman U . Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study. J Natl Cancer Inst. 2000; 92(23):1910-7. DOI: 10.1093/jnci/92.23.1910. View

12.

Sanders J, Chattopadhyay N, Kifor O, Yamaguchi T, Brown E . Ca(2+)-sensing receptor expression and PTHrP secretion in PC-3 human prostate cancer cells. Am J Physiol Endocrinol Metab. 2001; 281(6):E1267-74. DOI: 10.1152/ajpendo.2001.281.6.E1267. View

13.

Pyy L, Makela M, Hakala E, Kakko K, Lapinlampi T, Lisko A . Ambient and biological monitoring of exposure to polycyclic aromatic hydrocarbons at a coking plant. Sci Total Environ. 1997; 199(1-2):151-8. DOI: 10.1016/s0048-9697(97)00065-x. View

14.

Gill B, Kumar S, Navgeet . Evaluating anti-oxidant potential of ganoderic acid A in STAT 3 pathway in prostate cancer. Mol Biol Rep. 2016; 43(12):1411-1422. DOI: 10.1007/s11033-016-4074-z. View

15.

Yang M, Kenfield S, Van Blarigan E, Wilson K, Batista J, Sesso H . Dairy intake after prostate cancer diagnosis in relation to disease-specific and total mortality. Int J Cancer. 2015; 137(10):2462-9. PMC: 4754664. DOI: 10.1002/ijc.29608. View

16.

Slattery M, Schumacher M, West D, Robison L, French T . Food-consumption trends between adolescent and adult years and subsequent risk of prostate cancer. Am J Clin Nutr. 1990; 52(4):752-7. DOI: 10.1093/ajcn/52.4.752. View

17.

Yun B, Xiao S, Yao L, Krishnamachari S, Rosenquist T, Dickman K . A Rapid Throughput Method To Extract DNA from Formalin-Fixed Paraffin-Embedded Tissues for Biomonitoring Carcinogenic DNA Adducts. Chem Res Toxicol. 2017; 30(12):2130-2139. PMC: 5822421. DOI: 10.1021/acs.chemrestox.7b00218. View

18.

Richmond P, Karayiannakis A, Nagafuchi A, Kaisary A, Pignatelli M . Aberrant E-cadherin and alpha-catenin expression in prostate cancer: correlation with patient survival. Cancer Res. 1997; 57(15):3189-93. View

19.

Ahn-Jarvis J, Clinton S, Grainger E, Riedl K, Schwartz S, Lee M . Isoflavone pharmacokinetics and metabolism after consumption of a standardized soy and soy-almond bread in men with asymptomatic prostate cancer. Cancer Prev Res (Phila). 2015; 8(11):1045-54. PMC: 4633369. DOI: 10.1158/1940-6207.CAPR-14-0465. View

20.

Shaneyfelt T, Husein R, Bubley G, Mantzoros C . Hormonal predictors of prostate cancer: a meta-analysis. J Clin Oncol. 2000; 18(4):847-53. DOI: 10.1200/JCO.2000.18.4.847. View